Paper Details

  1. Home
  2. Paper Details

Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins.

Author: FrialTony, MillerPaul S J, TranYvan B L

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Generic statins may be a cost-effective alternative to brand-name statins for managing dyslipidemia.
Paper Details　
Original Abstract of the Article :
Generic statins may be considered as a compelling treatment option for managing dyslipidemia, due to their reduced cost, compared to their brand name equivalent. However, further assessment is needed to determine whether using a particular generic statin is more cost-effective relative to other bran...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17556788

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Dyslipidemia: A Cost-Effective Approach

Dyslipidemia, an imbalance of cholesterol and other fats in the blood, is a major risk factor for cardiovascular disease. This study investigates the cost-effectiveness of using generic statins, a widely prescribed class of drugs to manage dyslipidemia, compared to their brand-name equivalents. The researchers found that generic statins offered a compelling treatment option due to their lower cost while maintaining comparable efficacy to their brand-name counterparts.

Finding an Oasis in the Desert of Dyslipidemia: Generic Statins

This study provides strong evidence for the cost-effectiveness of generic statins in managing dyslipidemia. The findings suggest that generic statins, while significantly less expensive, offer comparable efficacy to their brand-name equivalents. This information can help guide clinicians in making informed decisions about medication selection for patients with dyslipidemia, promoting both cost savings and optimal patient outcomes.

Cost-Effective Choices for a Healthier Future

This study highlights the importance of considering cost-effectiveness in medication selection, particularly in managing chronic conditions like dyslipidemia. The findings provide strong evidence for the value of generic medications, offering a more affordable path to managing dyslipidemia without compromising efficacy. This information can empower patients to have active conversations with their healthcare providers about medication choices and promote greater access to cost-effective treatment options.

Dr.Camel's Conclusion

This study shines a light on the cost-effectiveness of generic statins, offering a welcome oasis in the vast desert of dyslipidemia management. The findings suggest that generic statins, while significantly less expensive, offer comparable efficacy to their brand-name counterparts. This research underscores the importance of considering cost-effectiveness in medication selection, promoting both patient affordability and optimal health outcomes.

Date :
  1. Date Completed 2007-06-27
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17556788

DOI: Digital Object Identifier

17556788

Related Literature

Article Analysis
・Effective treatment of statins
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.